← Back to Clinical Trials
Recruiting NCT05912972

NCT05912972 Development and Management of Registry in Patients With Gynecologic Cancer in Korea

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05912972
Status Recruiting
Phase
Sponsor Asan Medical Center
Condition Cervical Cancer
Study Type OBSERVATIONAL
Enrollment 13,500 participants
Start Date 2022-10-21
Primary Completion 2027-10-21

Trial Parameters

Condition Cervical Cancer
Sponsor Asan Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 13,500
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2022-10-21
Completion 2027-10-21
Interventions
Patient registry

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.

Eligibility Criteria

Inclusion Criteria: * Female patients 18 years or older * Written informed consent (prospective cohort) * Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer Exclusion Criteria: * Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology